Want to see FR:IPH full AI Analyst Report?
Innate Pharma SA (IPH) Stock Forecast & Price Target
10 Followers
IPH Analyst Ratings
There are no analyst ratings in the last 3 months.
IPH Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | EUR 1 | hold | -16.25%Downside | Reiterated | 11/03/26 | ||
| Google Biotechnology | TipRanks - Google | EUR 1.50 | hold | 25.63%Upside | Reiterated | 11/03/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | EUR 1 | hold | -16.25%Downside | Reiterated | 11/03/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | EUR 1 | hold | -16.25%Downside | Reiterated | 11/03/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | EUR 1.50→EUR 1 | hold | -16.25%Downside | Reiterated | 11/03/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | EUR 1.50→EUR 1 | hold | -16.25%Downside | Reiterated | 11/03/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | HoldReiteratedEUR 1 | 11/03/26 | -16.25%Downside | ||
| Google BiotechnologyTipRanks - Google | HoldReiteratedEUR 1.50 | 11/03/26 | 25.63%Upside | ||
| Anthropic BiotechnologyTipRanks - Anthropic | HoldReiteratedEUR 1 | 11/03/26 | -16.25%Downside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiteratedEUR 1 | 11/03/26 | -16.25%Downside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | HoldReiteratedEUR 1.50→EUR 1 | 11/03/26 | -16.25%Downside | ||
| xAI - Grok-4.3TipRanks - xAI | HoldReiteratedEUR 1.50→EUR 1 | 11/03/26 | -16.25%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
IPH Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, IPH has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IPH average Analyst price target in the past 3 months is ―.
IPH Financial Forecast
HighEUR -0.25
ConsensusEUR -0.25
LowEUR -0.25
IPH Earnings Forecast
Next quarter’s earnings estimate for IPH is -EUR 0.25 with a range of -EUR 0.25 to -EUR 0.25. The previous quarter’s EPS was -EUR 0.21. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 2.54M
ConsensusEUR 2.54M
LowEUR 2.54M
IPH Sales Forecast
Next quarter’s sales forecast for IPH is EUR 2.54M with a range of EUR 2.54M to EUR 2.54M. The previous quarter’s sales results were EUR 3.12M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
IPH Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Innate Pharma SA?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Innate Pharma SA?
To buy shares of FR:IPH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
